0000950170-24-075730.txt : 20240620 0000950170-24-075730.hdr.sgml : 20240620 20240620170321 ACCESSION NUMBER: 0000950170-24-075730 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240618 FILED AS OF DATE: 20240620 DATE AS OF CHANGE: 20240620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shook David CENTRAL INDEX KEY: 0001959742 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39370 FILM NUMBER: 241057329 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nkarta, Inc. CENTRAL INDEX KEY: 0001787400 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474515206 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1150 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (925) 407-1049 MAIL ADDRESS: STREET 1: 1150 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 ownership.xml 4 X0508 4 2024-06-18 0001787400 Nkarta, Inc. NKTX 0001959742 Shook David C/O NKARTA, INC. 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 false true false false Chief Medical Officer false Common Stock 2024-06-18 4 S false 456 5.60 D 116524 D Represents shares sold as required by the applicable award terms to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $5.59 to $5.60. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Alicia Hager 2024-06-20